Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Highlights of Skin Disease Education Foundations 42nd Annual Hawaii Dermatology Seminar.

Baldwin HE, Stein Gold LF, Gordon KB, Green JB, Leonardi CL, Sengelmann RD.

Semin Cutan Med Surg. 2018 Jun;37(4S):S75-S84. doi: 10.12788/j.sder.2018.031.

PMID:
30016379
2.

Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics.

Green JB, Hernandez AF, D'Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV.

Am Heart J. 2018 Jun 12;203:30-38. doi: 10.1016/j.ahj.2018.03.030. [Epub ahead of print]

PMID:
30015066
3.

Intestinal β-carotene bioconversion in humans is determined by a new single-sample, plasma isotope ratio method and compared with traditional and modified area-under-the-curve methods.

Ford JL, Green MH, Green JB, Oxley A, Lietz G.

Arch Biochem Biophys. 2018 Jun 27;653:121-126. doi: 10.1016/j.abb.2018.06.015. [Epub ahead of print]

PMID:
29958897
4.

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.

Alfredsson J, Green JB, Stevens SR, Reed SD, Armstrong PW, Angelyn Bethel M, Engel SS, McGuire DK, Van de Werf F, Hramiak I, White HD, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Obes Metab. 2018 Jun 19. doi: 10.1111/dom.13377. [Epub ahead of print]

PMID:
29923323
5.

Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB.

Am J Manag Care. 2018 Apr;24(8 Suppl):S146-S155.

6.

Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB.

Am J Manag Care. 2018 Apr;24(8 Suppl):S138-S145.

7.

Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Reed SD, Li Y, Leal J, Radican L, Adler AI, Alfredsson J, Buse JB, Green JB, Kaufman KD, Riefflin A, Van de Werf F, Peterson ED, Gray AM, Holman RR; TECOS Study Group.

Diabetes Obes Metab. 2018 Jul;20(7):1732-1739. doi: 10.1111/dom.13292. Epub 2018 Apr 20.

PMID:
29573215
8.

Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain.

Ehrhardt KP Jr, Mothersele SM, Brunk AJ, Green JB, Jones MR, Billeaud CB, Kaye AD.

Curr Pain Headache Rep. 2018 Mar 19;22(4):26. doi: 10.1007/s11916-018-0680-x. Review.

PMID:
29556832
9.

The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns.

Keaney TC, Anolik R, Braz A, Eidelman M, Eviatar JA, Green JB, Jones DH, Narurkar VA, Rossi AM, Gallagher CJ.

J Drugs Dermatol. 2018 Jan 1;17(1):19-28.

PMID:
29320584
10.

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.

Standl E, Stevens SR, Armstrong PW, Buse JB, Chan JCN, Green JB, Lachin JM, Scheen A, Travert F, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2018 Mar;41(3):596-603. doi: 10.2337/dc17-1778. Epub 2018 Jan 8.

PMID:
29311155
11.

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.

Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, Green JB, Buse JB, Inzucchi SE, Leiter LA, Raz I, Rosenstock J, Riddle MC.

Diabetes Care. 2018 Jan;41(1):14-31. doi: 10.2337/dci17-0057.

PMID:
29263194
12.

Combined aesthetic interventions for prevention of facial ageing, and restoration and beautification of face and body.

Fabi S, Pavicic T, Braz A, Green JB, Seo K, van Loghem JA.

Clin Cosmet Investig Dermatol. 2017 Oct 30;10:423-429. doi: 10.2147/CCID.S144282. eCollection 2017.

13.

Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive Behaviors.

Rossi AM, Eviatar J, Green JB, Anolik R, Eidelman M, Keaney TC, Narurkar V, Jones D, Kolodziejczyk J, Drinkwater A, Gallagher CJ.

Dermatol Surg. 2017 Nov;43 Suppl 2:S210-S220. doi: 10.1097/DSS.0000000000001293.

PMID:
29064988
14.

Aesthetic Treatment With Botulinum Toxin: Approaches Specific to Men.

Green JB, Keaney TC.

Dermatol Surg. 2017 Nov;43 Suppl 2:S153-S156. doi: 10.1097/DSS.0000000000001375. Review.

PMID:
29064978
15.

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.

Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2017 Dec;40(12):1763-1770. doi: 10.2337/dc17-1091. Epub 2017 Oct 6.

PMID:
28986504
16.

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.

Navar AM, Gallup DS, Lokhnygina Y, Green JB, McGuire DK, Armstrong PW, Buse JB, Engel SS, Lachin JM, Standl E, Van de Werf F, Holman RR, Peterson ED; TECOS Study Group.

Hypertension. 2017 Nov;70(5):907-914. doi: 10.1161/HYPERTENSIONAHA.117.09482. Epub 2017 Aug 28.

PMID:
28847886
17.

The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.

Butler J, Hamo CE, Filippatos G, Pocock SJ, Bernstein RA, Brueckmann M, Cheung AK, George JT, Green JB, Januzzi JL, Kaul S, Lam CSP, Lip GYH, Marx N, McCullough PA, Mehta CR, Ponikowski P, Rosenstock J, Sattar N, Salsali A, Scirica BM, Shah SJ, Tsutsui H, Verma S, Wanner C, Woerle HJ, Zannad F, Anker SD; EMPEROR Trials Program.

Eur J Heart Fail. 2017 Nov;19(11):1390-1400. doi: 10.1002/ejhf.933. Epub 2017 Aug 24. Review.

PMID:
28836359
18.

A Simple Plasma Retinol Isotope Ratio Method for Estimating β-Carotene Relative Bioefficacy in Humans: Validation with the Use of Model-Based Compartmental Analysis.

Ford JL, Green JB, Lietz G, Oxley A, Green MH.

J Nutr. 2017 Sep;147(9):1806-1814. doi: 10.3945/jn.117.252361. Epub 2017 Jul 26.

PMID:
28747484
19.

Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions.

Herbst R, Bolton W, Shariff A, Green JB.

Curr Diab Rep. 2017 Sep;17(9):67. doi: 10.1007/s11892-017-0898-8. Review.

PMID:
28726152
21.

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED; TECOS Study Group.

Circulation. 2017 Sep 26;136(13):1193-1203. doi: 10.1161/CIRCULATIONAHA.117.027252. Epub 2017 Jun 16.

PMID:
28626088
22.

Physician variation in lung cancer treatment at the end of life.

Green JB, Shapiro MF, Ettner SL, Malin J, Ang A, Wong MD.

Am J Manag Care. 2017 Apr;23(4):216-223.

23.

Pulmonary Vasodilators and Anesthesia Considerations.

Green JB, Hart B, Cornett EM, Kaye AD, Salehi A, Fox CJ.

Anesthesiol Clin. 2017 Jun;35(2):221-232. doi: 10.1016/j.anclin.2017.01.008. Epub 2017 Apr 14. Review.

PMID:
28526144
24.

Systems morphodynamics: understanding the development of tissue hardware.

Mao Y, Green JB.

Philos Trans R Soc Lond B Biol Sci. 2017 May 19;372(1720). pii: 20160505. doi: 10.1098/rstb.2016.0505.

25.

Cellular systems for epithelial invagination.

Pearl EJ, Li J, Green JB.

Philos Trans R Soc Lond B Biol Sci. 2017 May 19;372(1720). pii: 20150526. doi: 10.1098/rstb.2015.0526. Review.

26.

From snapshots to movies: Understanding early tooth development in four dimensions.

Kim R, Green JBA, Klein OD.

Dev Dyn. 2017 Jun;246(6):442-450. doi: 10.1002/dvdy.24501. Epub 2017 Apr 11. Review.

27.

Discovery of true electrochemical reactions for ultrahigh catalyst mass activity in water splitting.

Mo J, Kang Z, Retterer ST, Cullen DA, Toops TJ, Green JB Jr, Mench MM, Zhang FY.

Sci Adv. 2016 Nov 18;2(11):e1600690. doi: 10.1126/sciadv.1600690. eCollection 2016 Nov.

28.

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Bethel MA, Engel SS, Green JB, Huang Z, Josse RG, Kaufman KD, Standl E, Suryawanshi S, Van de Werf F, McGuire DK, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2017 Apr;40(4):494-501. doi: 10.2337/dc16-1135. Epub 2017 Jan 5.

PMID:
28057693
29.
30.

Management of newly treated diabetes in Medicare beneficiaries with and without heart failure.

Cooper LB, Mi X, Mentz RJ, Green JB, Anstrom KJ, Hernandez AF, Curtis LH.

Clin Cardiol. 2017 Jan;40(1):38-45. doi: 10.1002/clc.22603. Epub 2016 Oct 26.

31.

ASDS Cosmetic Dermatologic Surgery Fellowship Milestones.

Waldman A, Arndt KA, Avram MM, Brown MR, Dover JS, Fabi SG, Friedmann DP, Geronemus RG, Goldberg DJ, Goldman MP, Green JB, Ibrahimi OA, Jones DH, Kilmer SL, McDaniel DH, Obagi S, Ortiz AE, Rohrer TE, Taylor MB, Torres A, Weinkle SH, Weiss MA, Weiss ET, Weiss RA, Poon E, Alam M.

Dermatol Surg. 2016 Oct;42(10):1164-73. doi: 10.1097/DSS.0000000000000860.

PMID:
27661429
32.

Pancreatic Safety of Sitagliptin in the TECOS Study.

Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14.

33.

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.

Josse RG, Majumdar SR, Zheng Y, Adler A, Bethel MA, Buse JB, Green JB, Kaufman KD, Rodbard HW, Tankova T, Westerhout CM, Peterson ED, Holman RR, Armstrong PW; TECOS Study Group.

Diabetes Obes Metab. 2017 Jan;19(1):78-86. doi: 10.1111/dom.12786. Epub 2016 Oct 6.

PMID:
27607571
34.

Cosmetic Use of AbobotulinumtoxinA in Men: Considerations Regarding Anatomical Differences and Product Characteristics.

Bloom JD, Green JB, Bowe W, von Grote E, Nogueira A.

J Drugs Dermatol. 2016 Sep 1;15(9):1056-62. Review.

PMID:
27602966
35.

Plasma Retinol Kinetics and β-Carotene Bioefficacy Are Quantified by Model-Based Compartmental Analysis in Healthy Young Adults with Low Vitamin A Stores.

Green MH, Ford JL, Oxley A, Green JB, Park H, Berry P, Boddy AV, Lietz G.

J Nutr. 2016 Oct;146(10):2129-2136. Epub 2016 Aug 10.

36.

A Retinol Isotope Dilution Equation Predicts Both Group and Individual Total Body Vitamin A Stores in Adults Based on Data from an Early Postdosing Blood Sample.

Green MH, Ford JL, Green JB, Berry P, Boddy AV, Oxley A, Lietz G.

J Nutr. 2016 Oct;146(10):2137-2142. Epub 2016 Aug 10.

37.

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.

McGuire DK, Van de Werf F, Armstrong PW, Standl E, Koglin J, Green JB, Bethel MA, Cornel JH, Lopes RD, Halvorsen S, Ambrosio G, Buse JB, Josse RG, Lachin JM, Pencina MJ, Garg J, Lokhnygina Y, Holman RR, Peterson ED; Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group.

JAMA Cardiol. 2016 May 1;1(2):126-35. doi: 10.1001/jamacardio.2016.0103.

PMID:
27437883
38.

Current cardiovascular outcomes trials in type 2 diabetes: Perspectives and insight.

Coch RW, Green JB.

Nutr Metab Cardiovasc Dis. 2016 Sep;26(9):767-72. doi: 10.1016/j.numecd.2016.06.004. Epub 2016 Jun 16. Review.

PMID:
27378397
39.

Microfocused Ultrasound for Facial Photorejuvenation: A Review.

Wulkan AJ, Fabi SG, Green JB.

Facial Plast Surg. 2016 Jun;32(3):269-75. doi: 10.1055/s-0036-1584129. Epub 2016 Jun 1. Review.

PMID:
27248024
40.

Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?

Barnard K, Lakey WC, Batch BC, Chiswell K, Tasneem A, Green JB.

PLoS One. 2016 May 18;11(5):e0156068. doi: 10.1371/journal.pone.0156068. eCollection 2016.

41.

Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers: Safety and Current Use.

Fabi SG, Goldman MP, Mills DC, Werschler WP, Green JB, Kaufman J, Weiss RA, Hornfeldt CS.

Dermatol Surg. 2016 May;42 Suppl 2:S168-76. doi: 10.1097/DSS.0000000000000751.

PMID:
27128245
42.

Rejuvenation of the Aging Arm: Multimodal Combination Therapy for Optimal Results.

Wu DC, Green JB.

Dermatol Surg. 2016 May;42 Suppl 2:S119-23. doi: 10.1097/DSS.0000000000000732. Review.

PMID:
27128237
43.

Epiboly generates the epidermal basal monolayer and spreads the nascent mammalian skin to enclose the embryonic body.

Panousopoulou E, Hobbs C, Mason I, Green JB, Formstone CJ.

J Cell Sci. 2016 May 1;129(9):1915-27. doi: 10.1242/jcs.180703. Epub 2016 Mar 17.

44.

Invagination of Ectodermal Placodes Is Driven by Cell Intercalation-Mediated Contraction of the Suprabasal Tissue Canopy.

Panousopoulou E, Green JB.

PLoS Biol. 2016 Mar 9;14(3):e1002405. doi: 10.1371/journal.pbio.1002405. eCollection 2016 Mar.

45.

Epithelial stratification and placode invagination are separable functions in early morphogenesis of the molar tooth.

Li J, Chatzeli L, Panousopoulou E, Tucker AS, Green JB.

Development. 2016 Feb 15;143(4):670-81. doi: 10.1242/dev.130187. Epub 2016 Jan 11.

46.
47.

Introduction.

Cohen JL, Green JB.

Semin Cutan Med Surg. 2015 Sep;34(3):117. No abstract available.

PMID:
26682338
48.

Cellfina observations: pearls and pitfalls.

Green JB, Cohen JL.

Semin Cutan Med Surg. 2015 Sep;34(3):144-6.

PMID:
26682337
49.

Additional thoughts on the new treatment Kybella.

Cohen JL, Chen DL, Green JB, Joseph JH.

Semin Cutan Med Surg. 2015 Sep;34(3):138-9.

PMID:
26682336
50.

Therapeutic approaches to cellulite.

Green JB, Cohen JL, Kaufman J, Metelitsa AI, Kaminer MS.

Semin Cutan Med Surg. 2015 Sep;34(3):140-3. doi: 10.12788/j.sder.2015.0169. Review.

PMID:
26566570

Supplemental Content

Loading ...
Support Center